FDA.reportPublic FDA data

Complement components C3/C3c IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the quantitative measurement of complement cascade components C3 and/or C3c in a clinical specimen.
GUDID devices
7
Last updated
2025-03-26 08:21:28

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
B502BSB9042CS0C3c Control SlidesBIO SB, INC.BSB-9042-CS2025-03-18
B502BSB30320C3c control slidesBIO SB, INC.Control Slides, 52020-06-30
B502BSB3002CS0C3c / FITC control slides BIO SB, INC.control slides, 52020-09-30
L502BSB3032C3c control slidesBIO SB, INC.Control Slides, 52020-06-30
10888234000914Complement Control CellsIMMUCOR, INC.00079302016-04-15
05051700018876Human C3c Control Pack for use on the SPAPLUS®THE BINDING SITE GROUP LIMITEDNQ023.S2017-06-05
05051700019156Optilite® C3c Control PackTHE BINDING SITE GROUP LIMITEDNQ023.OPT2017-08-02